BioCorRx (BICX) Shares Outstanding (Weighted Average) (2010 - 2026)

BioCorRx's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $28.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 91.5% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at $28.9 million (up 91.5% YoY), while the FY2025 annual figure was $24.5 million, up 134.03% from the prior year.
• Shares Outstanding (Weighted Average) came in at $28.9 million for Q1 2026 at BioCorRx, up from $24.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $28.9 million in Q1 2026 to a low of $6.9 million in Q1 2022.
• A 5-year average of $12.1 million and a median of $8.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) increased 5.46% in 2022 and surged 134.03% in 2025, its largest moves.
• BioCorRx's Shares Outstanding (Weighted Average) stood at $7.2 million in 2022, then climbed by 15.92% to $8.3 million in 2023, then rose by 25.41% to $10.5 million in 2024, then surged by 134.03% to $24.5 million in 2025, then grew by 18.04% to $28.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $28.9 million, $24.5 million, and $20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison